Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
AlphaGenome 2 is an advanced AI framework and research platform dedicated to examining the impact of DNA sequences on gene regulation and associated molecular mechanisms. By inputting DNA sequences, it can forecast various molecular characteristics, thereby assisting researchers in exploring regulatory functions, gene expression patterns, splicing, chromatin accessibility, and a range of other genomic indicators. This tool is specifically tailored for scientists focused on understanding gene functions, the repercussions of genetic variants, and the biology of diseases, catering to both academic and noncommercial research entities. Accessible via an online API, it provides developer tools that facilitate the submission of sequences and the retrieval of predictions that support computational analyses. In turn, researchers can leverage these predictions to prioritize their hypotheses and guide subsequent experiments effectively. It is crucial to note that AlphaGenome 2 is strictly meant for research applications and has not undergone validation or received approval for clinical or diagnostic use, ensuring that users are aware of its intended scope and limitations. This emphasis on research utility highlights the importance of responsible application in scientific endeavors.
Description
Harnessing RNA sequencing (RNA-seq) data alongside Artificial Intelligence presents both a crucial necessity and a significant opportunity for creating therapies aimed at correcting splicing errors. By leveraging machine learning, we can uncover novel splicing errors and swiftly formulate therapeutic compounds to address them. Our AI platform, SpliceCore, is specifically designed for discovering RNA therapeutics. This cutting-edge technology focuses on analyzing RNA sequencing data with unparalleled efficiency. It can swiftly identify, evaluate, and validate potential drug targets, outpacing traditional methodologies. Central to SpliceCore is our unique repository containing over 5 million potential RNA splicing errors, making it the largest of its kind globally and instrumental for testing any RNA sequencing dataset submitted for analysis. The integration of scalable cloud computing allows us to handle vast quantities of RNA sequencing data in a way that is not only efficient but also cost-effective, significantly speeding up the pace of therapeutic advancements. This innovative approach promises to revolutionize the landscape of RNA therapeutics.
API Access
Has API
Yes
API Access
Has API
No
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
The AlphaGenome API is free of charge for noncommercial use. Commercial research access is in private preview.
Free Trial
No
Free Version
Yes
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
Yes
Vendor Details
Company Name
Google DeepMind
Founded
2010
Country
United Kingdom
Website
deepmind.google/science/alphagenome/
Vendor Details
Company Name
Envisagenics
Founded
2014
Country
United States
Website
www.envisagenics.com/platform/